Introduction

Lactobacillus casei is one of the most widely recognized and utilized probiotic species, known for its versatility across different human ecological niches. As a member of the lactic acid bacteria group, it plays a significant role in maintaining microbial balance and supporting host immunity. Through metagenomic shotgun sequencing and clinical trials, researchers have uncovered how different strains of L. casei interact with the host to promote health and mitigate the effects of dysbiosis in both the gastrointestinal tract and the oral cavity.

Location of Microbe

Gut Ecosystem

In the gut, Lactobacillus casei is found as part of the commensal microbiota, particularly in the small and large intestines, where it interacts with epithelial cells to maintain barrier integrity.

Oral Ecosystem

Within the oral cavity, L. casei is present in saliva and dental biofilms, where it exists as part of the complex microbial community on tooth surfaces and mucosal membranes.

Behavior During Dysbiosis

Gut Ecosystem

During gut dysbiosis, such as in acute or chronic kidney disease or IBD, L. casei can be used to restore short-chain fatty acid (SCFA) producing populations and reduce inflammatory signaling.

Oral Ecosystem

In the oral cavity, dysbiosis is marked by a loss of diversity and increased dominance of certain species; L. casei is found to be distinctly overabundant in carious dentin lesions.

Disease Associations

Gut Ecosystem

Inflammatory Bowel Disease (IBD)

Certain strains, such as L. casei M2S01, are associated with the alleviation of colitis. These strains may inhibit the NF-κB pathway and promote the expression of anti-inflammatory cytokines like IL-10 and IL-22, helping to restore a healthy microbiome composition and recover body weight in affected models.

Colorectal Cancer (CRC)

L. casei is associated with antitumor potential in CRC by triggering apoptosis through mitochondrial and death receptor routes and limiting cell division. It may also shift the gut microbiota toward protective taxa while suppressing species linked to carcinogens.

Metabolic and Systemic Conditions

Increased abundance of L. casei subgroups is associated with improved glucometabolic parameters in Type 2 Diabetes Mellitus (T2DM). Additionally, it is associated with reduced kidney inflammation in kidney disease and a potential reduction in pain markers for osteoarthritis.

Oral Ecosystem

Dentin Caries

Metagenomic analysis indicates that L. casei is significantly overabundant in samples from individuals with advanced dentin caries. This suggests an association with the shifted, less diverse microbiome characteristic of tooth decay, where it exists alongside other caries-associated bacteria.

Foods Supporting Healthy Balance

Maintaining a healthy balance of Lactobacillus casei involves the strategic use of prebiotics and synbiotics. Fructooligosaccharides (FOS) and galactooligosaccharides (GOS) are key prebiotics that can be fermented by L. casei, promoting its colonization and the production of short-chain fatty acids (SCFAs) like acetic acid. These metabolites help strengthen the gut barrier and maintain a stable environment.

Diets rich in fermented foods, vegetables, fruits, soybean, and rice have been positively correlated with a healthy microbial balance. In contrast, high intake of lamb has been associated with a decrease in beneficial taxa. For infants, the inclusion of specific carbohydrate fractions, such as those found in caprine milk, in combination with L. casei can further enhance intestinal barrier integrity and protect against pathogens.

Actionable Insights

• Synbiotic Support: Combining probiotics like L. casei with prebiotic fibers (such as inulin or FOS) may help increase the abundance of beneficial bifidobacteria and improve overall gastrointestinal well-being.
• Oral Hygiene: Given the association of certain oral microbes with halitosis and caries, maintaining rigorous oral hygiene and regularly changing face masks during prolonged use can help limit the overgrowth of opportunistic species.
• Strain Specificity: Be aware that the health benefits of L. casei are strain-specific; for example, strain M2S01 is noted for IBD-alleviating effects, while other strains may not provide the same benefit.
• Infant Health: Early colonization of the gut with L. casei (e.g., LGG) may promote a more even and stable microbial community, which is associated with a lower risk of developing allergic diseases and atopy later in childhood.

Conclusion

Lactobacillus casei serves as a multifaceted resident of the human body, with its impact heavily dependent on the specific strain and the ecological niche it occupies. In the gut, it acts as a powerful modulator of the immune system and a protector of the epithelial barrier, offering potential benefits for those with IBD or metabolic disorders. In the oral cavity, its role is more complex, appearing as a dominant species in the context of dentin caries. Ultimately, the balance of L. casei within these ecosystems is a key factor in overall preventive health, illustrating the intricate host-microbe interactions that define our wellbeing.